Crypto is stirring again. Bitcoin has pushed higher, altcoins are gaining momentum, and early signs point to a new cycle taking shape. In past rallies, some of the biggest equity winners were not just exchanges or miners but public companies tied directly to token treasuries and emerging blockchains. That setup may be returning now. A… Continue reading As Digital Assets Gain Momentum, These Stocks Offer an On-Ramp (DBKSF, MSTR, ABTC, STKE)
Mark MCKelvie
From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Artificial intelligence is moving beyond broad models and experimental tools. It is increasingly being applied to specific problems in defined industries where it can create measurable value. This includes sectors such as healthcare, enterprise software, defense, and industrial automation. The focus is shifting from general AI to specialized systems that improve performance, streamline operations, or… Continue reading From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
In the biotech sector, meaningful news often serves as the spark that brings smaller companies into sharper investor focus. Clinical readouts, regulatory decisions, and strategic acquisitions can materially shift the outlook for a business that may have otherwise flown under the radar. These developments not only shape the future of a company’s pipeline but can… Continue reading Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Crypto is once again showing signs of life. After spending much of the year grinding sideways, the market has shifted in recent weeks with Ethereum climbing back above $4,000 and money beginning to spill over into smaller tokens. The Altcoin Season Index, a closely watched gauge of capital rotation, flipped positive in late August, fueling… Continue reading Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
As the summer winds down, one market segment is starting to grab serious attention: digital asset treasuries. Public companies are increasingly adding cryptocurrencies such as Bitcoin, Ethereum, and Solana to their balance sheets as part of long-term strategies. What was once seen as a fringe experiment is now scaling, with corporate treasuries already holding more… Continue reading Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
The biotechnology sector is entering a dynamic growth phase, fueled by advances in gene therapy, AI-assisted drug discovery, and personalized medicine. Global biotech revenue is projected to grow from $1.55 trillion in 2024 to over $4.6 trillion by 2034, reflecting a surge in both investment and innovation. Venture funding is rebounding strongly, with billions pouring… Continue reading Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
The biotech sector is entering a pivotal phase fueled by scientific breakthroughs, accelerated regulatory approvals, and a surge of strategic dealmaking. The Nasdaq Biotechnology Index has posted strong gains, signaling renewed investor confidence. The FDA is clearing a record number of novel therapies, while global mergers and acquisitions have climbed past $105 billion, a seven… Continue reading Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
The crucial role of vaccines in protecting public health couldn’t have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023. At the height of the pandemic, Cominarty, which was jointly… Continue reading Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
After years of uncertainty, biotech is bouncing back. The Nasdaq Biotechnology Index is up over 18% year-to-date, outpacing the broader health care sector. Growth is fueled by paused interest rate hikes, record FDA approvals, and a surge in M&A activity topping $75 billion in the first half of 2025. Large pharma companies facing patent expirations… Continue reading Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)
The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum
Over the past few months, the once-niche drone market has evolved into a compelling, investable secular story. Regulatory friction is giving way to clarity. On August 5, 2025, the U.S. Department of Transportation, alongside the FAA and TSA, unveiled a Notice of Proposed Rulemaking (NPRM) aimed at normalizing Beyond Visual Line of Sight (BVLOS) drone… Continue reading The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum